Figure 3From: Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapiesDual probe design of the Cobas® Ampliprep™/Cobas® Taqman™ HCV 2.0 test second version. The introduction of a second labelled probe and an additional reverse primers increased mismatchs tolerance and assay’s accuracy.Back to article page